Skip to content

A Comparative Clinical Study Of Agnikarma And Viddhakarma In Cervical Spondylosis

A Comparative Clinical Study Of Agnikarma And Viddhakarma In Greeva Hundanam - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075994
Enrollment
40
Registered
2024-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Sponsors

Laxmi Dixit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Classical signs and symptoms of GreevaHundanam irrespective of their age,sex,occupation. 2 Patients between the age group of 18-60 years. 3 Patient voluntary willing to participate in the Clinical trial. 4 X-Ray showing radio logical signs for Cervical Spondylosis

Exclusion criteria

Exclusion criteria: 1 Patients of RA, Musculoskeletal disorder other than Greeva Hundanam. 2 Patients of uncontrolled DM and HTN. 3 Patients with any systemic disorder. 4 Patients with any Anatomical abnormalities. 5 Pregnant and Lactating mothers.

Design outcomes

Primary

MeasureTime frame
SUBJECTIVE The assessment of trial will be done based on improvement in the symptoms mentioned as- 1) Neck pain (GreevaShool). 2) Pricking sensation. 3) Stiffness (GreevaStambha). 4) Heaviness. 5) Vertigo (Bhrama)Timepoint: •Assessment will be carried out on intermittent days of 1 week i.e – on 1, 3, 5, 7 day to find out the efficacy of Agnikarma and Viddhakarma in Greeva Hundanam.

Secondary

MeasureTime frame
OBJECTIVE 1) Range of Motion. 2) Tenderness Over Cervical Region.Timepoint: Assessment will be carried out on intermittent days of 1 week i.e – on 1, 3, 5, 7 day to find out the efficacy of Agnikarma and Viddhakarma in Greeva Hundanam. • 1st follow up - 7 days after completion of treatment. • 2nd follow up - 15 days after 1st follow up. • 3rd follow up - 15 days after 2ndfollow up.

Countries

India

Contacts

Public ContactDr Laxmi Dixit

Quadra Institute of Ayurveda and Hospital

bhoomi629@gmail.com9008637659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026